Analyst firms · H.C. Wainwright · KRRO
H.C. Wainwright KRRO price target and rating history
Korro Bio Inc. (KRRO) · Health Care
H.C. Wainwright rates Korro Bio Inc. (KRRO) Buy with a $20 price target, as of its latest action on Jan 29, 2026. It has published 4 rating actions on KRRO since December 2023, including 1 upgrade and 1 downgrade. Across 7 firms with a KRRO price target in the last 12 months, the median target is $21. H.C. Wainwright's $20 is 5% below that.
- Current rating
- Buy
- Price target
- $20
- Median target, all firms
- $21
- Actions on KRRO
- 4
H.C. Wainwright price target on KRRO
Every H.C. Wainwright rating on KRRO
- Jan 29, 2026
- Nov 13, 2025
- Mar 28, 2024
- Dec 4, 2023
How other firms rate KRRO
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Citigroup | Buy | $21 | May 18, 2026 |
| Raymond James | Outperform | $23 | Mar 13, 2026 |
| William Blair | Outperform | Feb 17, 2026 | |
| Piper Sandler | Overweight | $30 | Jan 29, 2026 |
| Chardan Capital Markets | Buy | $15 | Jan 29, 2026 |
| H.C. Wainwright | Buy | $20 | Jan 29, 2026 |
| Cantor Fitzgerald | Overweight | $21 | Jan 28, 2026 |
| Oppenheimer | Outperform | $22 | Jan 28, 2026 |
Questions about H.C. Wainwright and KRRO
- What is H.C. Wainwright's price target for KRRO?
- H.C. Wainwright's latest stated price target for Korro Bio Inc. (KRRO) is $20, from its action on Jan 29, 2026.
- What is H.C. Wainwright's rating on KRRO?
- H.C. Wainwright rates KRRO Buy, a bullish rating, as of Jan 29, 2026.
- When did H.C. Wainwright last change its view on KRRO?
- On Jan 29, 2026, H.C. Wainwright upgrades to Buy from Neutral, price target $20.
- How does H.C. Wainwright's KRRO target compare with other analysts?
- Across 7 firms with a KRRO price target in the last 12 months, the median target is $21. H.C. Wainwright's $20 is 5% below that.
More KRRO rating histories
All H.C. Wainwright ratingsKRRO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.